Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study

Clinical trials suggested that the benefits of ezetimibe-statin combination therapy on major adverse cardiovascular events (MACE) might be greater in patients with diabetes. We aimed to investigate the differential association of ezetimibe-statin combination with incident MACE by presence of diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yong-ho, Hong, Namki, Lee, Chan Joo, Park, Sung Ha, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085319/
https://www.ncbi.nlm.nih.gov/pubmed/30093717
http://dx.doi.org/10.1038/s41598-018-30409-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085319/
https://www.ncbi.nlm.nih.gov/pubmed/30093717
http://dx.doi.org/10.1038/s41598-018-30409-6

Ejemplares similares